Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis
Cell Biochemistry and Function · 2026-11 · 44 (11)
DOI: 10.1002/cbf.70329 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, published online on 2026-11-01. Written by Weiwei Jiang and 1 co-authors. Institution: Department of Cardiovascular Medicine, The 970th Hospital of the Joint Logistic Support Force of the People's Liberation Army, Yantai, China. Major MEDLINE topics: Protein Processing, Post-Translational, Atherosclerosis, Endothelial Cells, Muscle, Smooth, Vascular. 217 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Atherosclerosis is driven by coordinated changes in endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs). Post‐translational modifications (PTMs), phosphorylation, acetylation, ubiquitination, SUMOylation, O‐GlcNAcylation, palmitoylation, ISGylation, and ADP‐ribosylation, integrate metabolic, inflammatory, and mechanical inputs at a limited number of signaling nodes. This review argues that these modifications interact according to four definable relationships rather than merely co‐occurring. In competitive cross‐talk, two marks contest one acceptor residue, as when O‐GlcNAcylation displaces phosphorylation at the Akt site of endothelial nitric oxide synthase. In hierarchical cross‐talk, one modification licenses another, as when Ser536 phosphorylation of NF‐κB p65 recruits p300 and permits Lys310 acetylation. In enzyme‐directed cross‐talk, a modification acts on the writer or eraser of a different system, as HDAC9 does on IκB kinases. In cofactor‐coupled cross‐talk, sirtuin‐dependent deacylation and PARP1‐dependent ADP‐ribosylation draw on one limiting NAD + pool. We rank nodes against four stated criteria, grade every finding on a five‐level evidence scheme, and apply the framework to phosphorylation–O‐GlcNAcylation, ubiquitination–SUMOylation, and acetylation–ubiquitination interactions across the three vascular cell types. Of the cross‐talk relationships invoked, five are supported at residue resolution by a substitution experiment, and two of these were obtained in vascular cells; the remainder are inferred from enzyme‐level regulation or from pathway convergence. Candidate intervention points include HDAC9, SENP3, OGT, UBA1, and the NAD + pool, none of which has been evaluated in a cardiovascular outcome trial.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiovascular Medicine, The 970th Hospital of the Joint Logistic Support Force of the People's Liberation Army, Yantai, China.
- Department of Cardiology, Yantaishan Hospital, Yantai, Shandong, China.
ORCID profiles: Haiping Du
Cite
APA
Jiang, W., & Du, H. (2026). Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70329
Vancouver
Jiang W, Du H. Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70329
BibTeX
@article{Jiang2026,
author = {Jiang, Weiwei and Du, Haiping},
title = {Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/cbf.70329}
}
EUVIMED